IntelGenx Grants Stock Options
GlobeNewswire - Mon Dec 08, 1:54PM CST
IntelGenx Technologies Corp. ("IntelGenx", or the "Company"
IGX.VN: 0.570 (unch)
IntelGenx Grants Extension of Marketing Exclusivity in the U.S. to Edgemont of Forfivo XL(R)
GlobeNewswire - Tue Dec 02, 6:32AM CST
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"
IGX.VN: 0.570 (unch)
German regulator starts review of Rizaport MAA
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 7:43AM CST
RDHL: 12.22 (-0.13)
IntelGenx and RedHill Biopharma Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines
GlobeNewswire - Mon Dec 01, 7:03AM CST
-- The German Federal Institute for Drugs and Medical Devices ("BfArM"
RDHL: 12.22 (-0.13), IGX.VN: 0.570 (unch)
RedHill Biopharma and IntelGenx Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines
GlobeNewswire - Mon Dec 01, 7:00AM CST
-- The German Federal Institute for Drugs and Medical Devices (BfArM) has validated the European Marketing Authorization Application submitted for RIZAPORT (RHB-103) and initiated its formal review of the application on November 25, 2014
RDHL: 12.22 (-0.13), IGX.VN: 0.570 (unch)
IntelGenx Announces Update to Settlement of U.S. Patent Litigation Related to Forfivo XL(R)
GlobeNewswire - Wed Nov 26, 7:41AM CST
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"
IGX.VN: 0.570 (unch)
IntelGenx Announces Settlement of U.S. Patent Litigation Related to Forfivo XL(R)
GlobeNewswire - Tue Nov 25, 7:08AM CST
IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) ("IntelGenx"
IGX.VN: 0.570 (unch)
Stocks to watch ahead of the "Best of the Uncovereds" conference
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 6:45AM CST
ACET: 21.85 (-0.07), ACU: 18.57 (unch), BONE: 2.59 (-0.02), MNTX: 11.74 (-0.19), TREC: 15.19 (+0.52), INTL: 19.91 (-0.28), HPJ: 5.03 (+0.14), SPA: 28.20 (-0.41), AXPW: 1.00 (-0.04), ADES: 20.77 (+0.15), DXPE: 51.55 (-0.41), LODE: 0.69 (-0.02), LABL: 54.82 (-0.05), NEWT: 13.37 (-0.22), SA: 7.03 (+0.22), PSEC: 8.59 (-0.02)
IntelGenx to Present at Singular Research's Best of the Uncovered 2014 NYC Fall Conference
GlobeNewswire - Tue Nov 18, 7:40AM CST
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"
IGX.VN: 0.570 (unch)
IntelGenx reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 9:19AM CST
IntelGenx Reports Q3, 2014 Results and Provides Corporate Development Update
GlobeNewswire - Wed Nov 12, 7:02AM CST
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"
IGX.VN: 0.570 (unch)
Small Cap Traders Delivers Brief Report: IntelGenx Technologies Corporation Targeting Better Outcomes
PR Newswire - Thu Nov 06, 6:00AM CST
Brief Analyst Report by Small Cap Traders. IntelGenx Technologies Corporation (OTCBB: IGXT) - According to a January 2014 report by BCCResearch, global revenues for advanced drug delivery systems in 2013 were an estimated $151.3 billion. Revenues for advanced drug delivery systems are estimated to grow by compound annual growth rate (CAGR) of 2.8% through 2018, reaching $173.8 billion. These targeted drug delivery systems are used to increase the concentration of medications in some parts of the human body relative to other parts. This reduces the frequency of drug dosages required by the patient, results in a more uniform effect from the drug, and lowers drug side-effects. One company involved in this industry is IntelGenx Technologies Corporation.
IntelGenx Announces Successful Clinical Study for Schizophrenia
GlobeNewswire - Mon Nov 03, 7:37AM CST
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx" or the "Company"
IGX.VN: 0.570 (unch)
This Small Cap Is Poised To Tap Multi-Billion Dollar Migraine Treatment Market
Tedra DeSue - at Seeking Alpha - Thu Oct 16, 8:14AM CDT
RDHL: 12.22 (-0.13)
IntelGenx Founder Returns as President and CEO
GlobeNewswire - Thu Oct 02, 7:02AM CDT
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"
IGX.VN: 0.570 (unch)
RedHill Biopharma and IntelGenx Submit European Marketing Authorization Application for Migraine Drug RIZAPORT(R) (formerly RHB-103)
GlobeNewswire - Wed Oct 01, 9:21AM CDT
RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill"
RDHL: 12.22 (-0.13), IGX.VN: 0.570 (unch)
IntelGenx and RedHill Biopharma Submit European Marketing Authorization Application for Migraine Drug RIZAPORT(R)
GlobeNewswire - Wed Oct 01, 9:21AM CDT
IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"
RDHL: 12.22 (-0.13), IGX.VN: 0.570 (unch)
IntelGenx to Present at Singular Research 9th Annual Best of the Uncovereds Conference
GlobeNewswire - Wed Sep 17, 8:28AM CDT
IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) ("IntelGenx"
IGX.VN: 0.570 (unch)